Fertility and Sterility
Volume 91, Issue 4 , Pages 1005-1011, April 2009

Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial

  • Valerie L. Baker, M.D.

      Affiliations

    • Obstetrics and Gynecology, Stanford University Medical Center, Stanford, California
    • Fertility Physicians of Northern California, San Jose, California
    • Corresponding Author InformationReprint requests: Valerie L. Baker, M.D., Stanford University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, 300 Pasteur Drive, Room HH333, Stanford, California 94305-5317 (FAX: 650-736-7036).
    • ,
  • Victor Y. Fujimoto, M.D.

      Affiliations

    • Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California
    • ,
  • L. Michael Kettel, M.D.

      Affiliations

    • San Diego Fertility Center, San Diego, California
    • ,
  • G. David Adamson, M.D.

      Affiliations

    • Fertility Physicians of Northern California, San Jose, California
    • ,
  • Fred Hoehler, Ph.D.

      Affiliations

    • Biostatistician Consultant, Orange, California
    • ,
  • Clarence E. Jones, Ph.D.

      Affiliations

    • Consultant, Huntington Beach, California
    • ,
  • Michael R. Soules, M.D.

      Affiliations

    • Seattle Reproductive Medicine, Seattle, Washington

Received 18 October 2007; received in revised form 15 January 2008; accepted 15 January 2008. published online 25 March 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study funded by Institut Biochimique SA (IBSA), Switzerland.

 Dr. Baker has received research support from IBSA. Dr. Adamson is CEO and Shareholder of Advanced Reproductive Care, is a physician owner of Fertility Physicians of Northern California, has received research support from IBSA, and has been a speaker for Ferring Pharmaceuticals. His spouse is also a shareholder in Advanced Reproductive Care. Dr Hoehler has served as a consultant to IBSA, Vital Therapies, Inc., Pioneer Surgical, Kyphon, Cooper Surgical, and Fziomed. Dr. Jones is a consultant for VitalTherapies, Inc., and IBSA, and as of 7/1/07, became an employee of IBSA. Drs. Fujimoto, Kettel, and Soules report no conflicts of interest.

PII: S0015-0282(08)00159-3

doi:10.1016/j.fertnstert.2008.01.064

Fertility and Sterility
Volume 91, Issue 4 , Pages 1005-1011, April 2009

Article Tools

* Image Usage & Resolution